1. О противозачаточных начистоту

Akinloye, O., et al. “Effects of Contraceptives on Serum Trace Elements, Calcium, and Phosphorus Levels”. West Indian Medical Journal 60, no. 3 (2011): 308–15.

Aminzadeh, A., et al. “Frequency of Candidiasis and Colonization of Candida Albicans in Relation to Oral Contraceptive Pills”. Iran Red Crescent Medical Journal 18, no. 10 (2016): e38909.

Anderson, K. E., et al. “Effects of Oral Contraceptives on Vitamin Metabolism”. Advances in Clinical Chemistry 18 (1976): 247–87.

Bird, S. T., et al. “Irritable Bowel Syndrome and Drospirenone-Containing Oral Contraceptives; A Comparative-Safety Study”. Current Drug Safety 7, no. 1 (2012): 8–15.

Centers for Disease Control, Cancer and Steroid Hormone Study. “Long-Term Oral Contraceptive Use and the Risk of Breast Cancer”. JAMA 249, no. 12 (1983): 1591–95.

Chasan-Taber, L., et al. “Epidemiology of Oral-Contraceptives and Cardiovascular Disease”. Annals of Internal Medicine 128, no. 6 (1998): 467–77.

Davidson, N. E., et al. “Good News About Oral Contraceptives”. New England Journal of Medicine 346 (2002): 2078–79.

Davis, A. R., et al. “Occurrence of Menses or Pregnancy After Cessation of a Continuous Oral Contraceptive”. Fertility and Sterility 89, no. 5 (2008): 1059–63.

Dreon, D. M., et al. “Oral Contraceptive Use and Increased Plasma Concentration of C-Reactive Protein”. Life Sciences 73, no. 10 (2003): 1245–52.

Dunn, N., et al. “Oral Contraceptives and Myocardial Infarction: Results of the MICA Case Control Study”. British Medical Journal 318, no. 7198 (1999): 1579–84.

Fröhlich, M., et al. “Oral Contraceptive Use Is Associated with a Systemic Acute Phase Response”. Fibrinolysis and Proteolysis 13, no. 6 (1999): 239–44.

Gingnell, M., et al. “Oral Contraceptive Use Changes Brain Activity and Mood in Women with Previous Negative Affect on the Pill – A Double-Blinded, Placebo-Controlled Randomized Trial of a Levonorgestrel-Containing Combined Oral Contraceptive”. Psychoneuroendocrinology 38, no. 7 (2013): 1133–44.

Hankinson, S. E., et al. “A Prospective Study of Oral Contraceptive Use and Risk of Breast Cancer (Nurses’ Health Study, United States)”. Cancer Causes and Control 8, no. 1 (1997): 65–72.

Hertel, J., et al. “Evidence for Stress-Like Alterations in the HPA-Axis in Women Taking Oral Contraceptives”. Scientific Reports 7, no. 1 (2017): 14111.

Hickman, R. J., et al. “C-Reactive Protein Is Elevated in Atypical but Not Nonatypical Depression: Data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004”. Journal of Behavioral Medicine 37, no. 4 (2014): 621–29.